4/A//SEC Filing
Dick Evan G. 4/A
Accession 0001842952-21-000025
CIK 0001842952other
Filed
Dec 16, 7:00 PM ET
Accepted
Dec 17, 4:12 PM ET
Size
7.1 KB
Accession
0001842952-21-000025
Insider Transaction Report
Form 4/AAmended
Dick Evan G.
SVP of R&D
Transactions
- Conversion
Common Stock
2021-10-22+26,587→ 82,960 total - Conversion
Series Seed Preferred Stock
2021-10-22−26,587→ 0 total→ Common Stock (26,587 underlying)
Footnotes (3)
- [F1]Each share of Series Seed Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering.
- [F2]Includes 33,397 restricted stock units which fully vest on January 31, 2023.
- [F3]Fully vested.
Documents
Issuer
Context Therapeutics Inc.
CIK 0001842952
Entity typeother
Related Parties
1- filerCIK 0001862116
Filing Metadata
- Form type
- 4/A
- Filed
- Dec 16, 7:00 PM ET
- Accepted
- Dec 17, 4:12 PM ET
- Size
- 7.1 KB